✦ LIBER ✦

High doses of cisplatin (C) plus 4'epidoxorubicin (E) vs. low doses of C + E or C + etoposide (V) in the treatment of non small cell lung cancer

Book ID: 123209025
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 179 KB
Volume: 2
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(86)80448-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced non-small cell lun

Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C

✍ Paul J. Hesketh; Sualp Tansan; Priscilla B. Caguioa; Ann Hesketh; Rita Blanchard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Treatment of advanced non-small cell lun

Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Random prospective study of vindesine ve

Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Comparison of vindesine plus cisplatin o

Comparison of vindesine plus cisplatin or mytomycin C in the treatment of advanced non-small cell lung cancer

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Phase II trial of very high dose cisplat

Phase II trial of very high dose cisplatin (DDP) and etoposide (VP-16) and mitomycin-C (Mito-C) in advanced non-small cell lung cancer (NSCLC)

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Etoposide versus etoposide plus high-dos

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

✍ Professor Riccardo Rosso; Franco Salvati; Andrea Ardizzoni; Corrado Gallo Curcio 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB